PTGS2 and urinary bladder cancer: This dual functionality—potent COX-2 pathway inhibition coupled with platinum-mediated cytotoxicity—positions DNP as a promising therapeutic candidate with enhanced efficacy–toxicity ratio for bladder cancer management.